XORTX Therapeutics (XRTX.V) Q4 2024 Earnings

Nov 14Confirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-1.69
-1.1
-0.51
0.08

Details

Expected EPS
-0.5387929064000001
Actual EPS
-0.407827
Surprise EPS
0.13
Surprise Percent
+24.31%

Description

⁨XORTX Therapeutics⁩ (⁦XRTX.V⁩) has reported earnings of ⁦-0.407827⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts